DS-6051b

· Daiichi Sankyo Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DS-6051b, covering 2024-12-16 to 2025-06-24. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b [Phase 1]